About Xcelom
Founded in 2014 by Professor Dennis Lo Yuk Ming and team, Xcelom is a genomics services provider and Hong Kong's largest NIPT provider operating under CUHK patent licenses. Our parent company, Berry Genomics, is China's second largest NIPT provider and the first to translate long-read sequencing into clinical use, with over 350,000 clinical LRS cases. We serve healthcare providers, laboratories, and organizations with reliable solutions across markets. Our portfolio covers sequencing-based screening and molecular diagnostics, including prenatal testing, carrier screening, and rare disease applications. We offer send-out testing, co-develop assays, and provide scalable end-to-end technology transfer so services can be run in-house. Deliverables include assay development, reagents, technical support and training, and bioinformatics/reporting/management software, supported by strong R&D capabilities and proven operational experience. Xcelom is the authorized sole representative of Berry Genomics for overseas business operations and the authorized distributor for Haorui Genomics laboratory solutions.
